These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

727 related articles for article (PubMed ID: 32632717)

  • 1. In Silico Screening of Potential Chinese Herbal Medicine Against COVID-19 by Targeting SARS-CoV-2 3CLpro and Angiotensin Converting Enzyme II Using Molecular Docking.
    Gao LQ; Xu J; Chen SD
    Chin J Integr Med; 2020 Jul; 26(7):527-532. PubMed ID: 32632717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study on screening potential traditional Chinese medicines against 2019-nCoV based on Mpro and PLP].
    Ma J; Huo XQ; Chen X; Zhu WX; Yao MC; Qiao YJ; Zhang YL
    Zhongguo Zhong Yao Za Zhi; 2020 Mar; 45(6):1219-1224. PubMed ID: 32281328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Network pharmacology, molecular docking integrated surface plasmon resonance technology reveals the mechanism of Toujie Quwen Granules against coronavirus disease 2019 pneumonia.
    Ye M; Luo G; Ye D; She M; Sun N; Lu YJ; Zheng J
    Phytomedicine; 2021 May; 85():153401. PubMed ID: 33191068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Network pharmacology and molecular docking analysis on molecular targets and mechanisms of Huashi Baidu formula in the treatment of COVID-19.
    Tao Q; Du J; Li X; Zeng J; Tan B; Xu J; Lin W; Chen XL
    Drug Dev Ind Pharm; 2020 Aug; 46(8):1345-1353. PubMed ID: 32643448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Rapid establishment of traditional Chinese medicine prevention and treatment of 2019-nCoV based on clinical experience and molecular docking].
    Niu M; Wang RL; Wang ZX; Zhang P; Bai ZF; Jing J; Guo YM; Zhao X; Zhan XY; Zhang ZT; Song XA; Qin EQ; Wang JB; Xiao XH
    Zhongguo Zhong Yao Za Zhi; 2020 Mar; 45(6):1213-1218. PubMed ID: 32281327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In silico analysis of the potential mechanism of a preventive Chinese medicine formula on coronavirus disease 2019.
    Wu H; Gong K; Qin Y; Yuan Z; Xia S; Zhang S; Yang J; Yang P; Li L; Xie M
    J Ethnopharmacol; 2021 Jul; 275():114098. PubMed ID: 33831468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In Silico Screening of Potential Spike Glycoprotein Inhibitors of SARS-CoV-2 with Drug Repurposing Strategy.
    Wei TZ; Wang H; Wu XQ; Lu Y; Guan SH; Dong FQ; Dong CL; Zhu GL; Bao YZ; Zhang J; Wang GY; Li HY
    Chin J Integr Med; 2020 Sep; 26(9):663-669. PubMed ID: 32740825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying potential treatments of COVID-19 from Traditional Chinese Medicine (TCM) by using a data-driven approach.
    Ren X; Shao XX; Li XX; Jia XH; Song T; Zhou WY; Wang P; Li Y; Wang XL; Cui QH; Qiu PJ; Zhao YG; Li XB; Zhang FC; Li ZY; Zhong Y; Wang ZG; Fu XJ
    J Ethnopharmacol; 2020 Aug; 258():112932. PubMed ID: 32376368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Traditional Chinese medicine network pharmacology study on exploring the mechanism of Xuebijing Injection in the treatment of coronavirus disease 2019.
    Xing Y; Hua YR; Shang J; Ge WH; Liao J
    Chin J Nat Med; 2020 Dec; 18(12):941-951. PubMed ID: 33357725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigating the active compounds and mechanism of HuaShi XuanFei formula for prevention and treatment of COVID-19 based on network pharmacology and molecular docking analysis.
    Wang J; Ge W; Peng X; Yuan L; He S; Fu X
    Mol Divers; 2022 Apr; 26(2):1175-1190. PubMed ID: 34105049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mechanism of
    Yan H; Zou Y; Zou C
    Nan Fang Yi Ke Da Xue Xue Bao; 2020 May; 40(5):616-623. PubMed ID: 32897211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the active components and mechanism of Shufeng Jiedu capsule against COVID-19 based on network pharmacology and molecular docking.
    Simayi J; Nuermaimaiti M; Wumaier A; Khan N; Yusufu M; Nuer M; Maihemuti N; Bayinsang ; Adurusul K; Zhou W
    Medicine (Baltimore); 2022 Jan; 101(1):e28286. PubMed ID: 35029877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In silico ADMET and molecular docking study on searching potential inhibitors from limonoids and triterpenoids for COVID-19.
    Vardhan S; Sahoo SK
    Comput Biol Med; 2020 Sep; 124():103936. PubMed ID: 32738628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the molecular mechanism of Pudilan (PDL) treatment for COVID-19 by network pharmacology tools.
    Kong Q; Wu Y; Gu Y; Lv Q; Qi F; Gong S; Chen X
    Biomed Pharmacother; 2020 Aug; 128():110316. PubMed ID: 32505821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scaffold morphing of arbidol (umifenovir) in search of multi-targeting therapy halting the interaction of SARS-CoV-2 with ACE2 and other proteases involved in COVID-19.
    Choudhary S; Silakari O
    Virus Res; 2020 Nov; 289():198146. PubMed ID: 32866534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential inhibitors of the interaction between ACE2 and SARS-CoV-2 (RBD), to develop a drug.
    Benítez-Cardoza CG; Vique-Sánchez JL
    Life Sci; 2020 Sep; 256():117970. PubMed ID: 32553928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Network pharmacology analysis of the therapeutic mechanisms of the traditional Chinese herbal formula Lian Hua Qing Wen in Corona virus disease 2019 (COVID-19), gives fundamental support to the clinical use of LHQW.
    Zheng S; Baak JP; Li S; Xiao W; Ren H; Yang H; Gan Y; Wen C
    Phytomedicine; 2020 Dec; 79():153336. PubMed ID: 32949888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prioritizing potential ACE2 inhibitors in the COVID-19 pandemic: Insights from a molecular mechanics-assisted structure-based virtual screening experiment.
    Teralı K; Baddal B; Gülcan HO
    J Mol Graph Model; 2020 Nov; 100():107697. PubMed ID: 32739642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Active constituents and mechanisms of Respiratory Detox Shot, a traditional Chinese medicine prescription, for COVID-19 control and prevention: Network-molecular docking-LC-MS
    Zhang ZJ; Wu WY; Hou JJ; Zhang LL; Li FF; Gao L; Wu XD; Shi JY; Zhang R; Long HL; Lei M; Wu WY; Guo DA; Chen KX; Hofmann LA; Ci ZH
    J Integr Med; 2020 May; 18(3):229-241. PubMed ID: 32307268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In silico study of azithromycin, chloroquine and hydroxychloroquine and their potential mechanisms of action against SARS-CoV-2 infection.
    Braz HLB; Silveira JAM; Marinho AD; de Moraes MEA; Moraes Filho MO; Monteiro HSA; Jorge RJB
    Int J Antimicrob Agents; 2020 Sep; 56(3):106119. PubMed ID: 32738306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.